Brought to you by:

lung disease

Lung model
Biotech

Infex advances lung disease candidate after clearing phase 2a

Infex is pushing ahead with development after posting phase 2a data, advancing efforts to enter a market served by Insmed’s Brinsupri.
Nick Paul Taylor May 21, 2026 4:29am
Sketch of lungs

With $30M, Oorja Bio breathes new life into fibrosis candidate

May 20, 2026 10:31am
helicopter rescue mission save aircraft

Cash-strapped Quince finds salvation in reverse merger

May 18, 2026 10:32am
Silhouette of Businessman Entering Lit Door Passage in Darkness

NIH loses another leader as heart, lung and blood director exits

Jan 13, 2026 4:00am
China export industry and global supply chain Cargo airplane flying over logistic containers

AirNexis swoops in with $200M series A for COPD asset

Jan 9, 2026 11:01am
pause halt pause button

Daiichi-Merck ph. 3 ADC program on pause after patient deaths

Dec 18, 2025 11:22am